References
1. El-Banayosy A, Arusoglu L, Morshuis M, Kizner L, Tenderich
G, Sarnowski P, Milting H, Koerfer R: CardioWest total artificial heart:
Bad Oeynhausen experience. Ann J Thorac Surg 2005; 80(2):548-52.
2. Copeland JG, Copeland H, Gustafson M, Mineburg N, Covington D, Smith
RG, Friedman M: Experience with more than 100 total artificial heart
implants. J Thorac Cardiovasc Surg 2012;143:727-34.
3. Wilson LD, Detterbeck F, Yahalom J. Clinical practice. Superior vena
cava syndrome with malignant causes. N Engl J Med 2007;356(18):1862-9.
4. Lepper PM, Ott SR, Hope H, Schumann C, Stammberger U Bugalho A, Frese
S, Schmucking M, Blumstein NM, Diehm N, Bals R, Jamacher J. Superior
Vena Cava Syndrome in Thoracic Malignancies. Respir Care
2011;56(5):653-666.
5. Nunnelee JD. Superior vena cava syndrome. J Vasc Nurs 2007; 25(1):
2-5 quiz 6
6. Strecker T, Zimmerman I, Heinz M, Rosch J, Agaimy A, Weyan M.
Successful venous angioplasty of superior vena cava syndrome after heart
transplantation. Case Rep Cardiol 2014; 2014:490276.
7. Kashani BS, Ahmadi ZH, Abdi S, Mirhosseini SM, Kianfar AA Niusha S.
Superior vena cava obstruction after heart transplantation. Asian
Cardiovasc Thorac Ann. 2016;24(1):88-90.
8. Metzer C, Lembcke A, Ziemer S, Eddicks S, Witte J, Baumann G, Borges
AC. Pacemaker induced superior vena cava syndrome: clinical evaluation
of long term follow-up. Pacing Clin Electrophysiol 2006;29(12):1346-51.
9. Rejjal L, Al-Taweel O, Alwash H, Choudhry M. Alghrouz M, Khalife W,
Morsy M, Al-Taweel A, Chatila K, Gilani K, Gilani S. Stent migration
during endovascular stenting in superior vena cava syndrome in a patient
with recent heart transplantation. JACC 2019;79(9):2741.
10. Kondruweit M, Strecker T, Seitz T, Uder M, Weyand M, Tandler R,
Stenting of the superior vena cava in a patient with a total artificial
heart. J Thorac Cardiovasc Surg 2008; 135:455-6.
11. Zimmerman H, Coehlo-Anderson R, Slepian M, Smith RG, Sethi G,
Copeland JG: Device malfunction of the CardioWest Total Artificial Heart
secondary to catheter entrapment of the tricuspid valve. ASAIO J
2010;56:481-82.
12. Spiliopoulos S, Dogan G, Guersoy D, Serrano MR, Koerfer R, Tenderich
G: veno-venous extracorporeal membrane oxygenation with a bicaval
dual-lumen catheter in a Syncardia total artificial heart patient. J
Cardiothorac Surg 2013; 8:179.
13. Lick SD, Tran PL, Kazui P, Smith RG, Khalpey ZI: Total Artificial
Heart, augmented by venovenous extracorporeal membrane oxygenation.
ASAIO J 2016;62(4): e35-6.
Figure 1: Angiographic catheter (5 French Berenstein, 65 cm
length, Torcon NB Beacon Tip, Cook, Inc., Bloomington, IN) inserted from
the right common femoral vein through a 9 French vascular sheath. The
tip of the catheter is situated in the upper portion of the inferior
vena cava prior to passage through the TAH and into the SVC.
Figure 2 : Superior venacavogram using a straight flush catheter
(5 French, 65 cm length, Boston Scientific, Marlborough MA). A
high-grade stenosis of the superior vena cava is evident.
Figure 3 : Angioplasty balloon catheter (14 mm diameter Atlas, 7
Fr, Bard Incorporated Tempe, AZ) positioned within the superior vena
cava. Balloon is in the process of being inflated and demonstrates the
site of vena cava stenosis (full inflation of the balloon not depicted).
Figure 4 : Further angioplasty performed with a larger diameter
balloon. Fully inflated 18 mm diameter angioplasty balloon (Atlas, 7 Fr,
Bard Inc., Tempe AZ) across the site of SVC stenosis.
Figure 5 : Repeat superior venacavogram shows no hemodynamically
significant residual stenosis.
FIGURE 1